Transvenous neurostimulation for central sleep apnoea: a randomised controlled trial
Transvenous neurostimulation for central sleep apnoea: a randomised controlled trial
About this item
Full title
Author / Creator
remedé System Pivotal Trial Study Group , Costanzo, Maria Rosa, Dr , Ponikowski, Piotr, Prof , Javaheri, Shahrokh, Prof , Augostini, Ralph, MD , Goldberg, Lee, MD , Holcomb, Richard, PhD , Kao, Andrew, MD , Khayat, Rami N, MD , Oldenburg, Olaf, Prof , Stellbrink, Christoph, Prof and Abraham, William T, Prof
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Summary Background Central sleep apnoea is a serious breathing disorder associated with poor outcomes. The remedé system (Respicardia Inc, Minnetonka, MN, USA) is an implantable device which transvenously stimulates a nerve causing diaphragmatic contraction similar to normal breathing. We evaluated the safety and effectiveness of unilateral neurost...
Alternative Titles
Full title
Transvenous neurostimulation for central sleep apnoea: a randomised controlled trial
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1979056494
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1979056494
Other Identifiers
ISSN
0140-6736
E-ISSN
1474-547X
DOI
10.1016/S0140-6736(16)30961-8
